Literature DB >> 7769179

Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children.

E Sujansky1, S Conradi.   

Abstract

Data were obtained on 171 individuals with Sturge-Weber syndrome via questionnaire and medical records. The age of the study group ranged from 2 months to 59 years; the median was 8 years. In addition to the facial location of port-wine stains in the areas of the trigeminal dermatomes present in 170 patients, 45% also had extracranial port-wine stains over the torso and/or extremities, and 17% had other vascular or pigmentary lesions. Seizures were present in 80% of all patients (87% of those with bilateral and 71% of those with unilateral port-wine stains); in all but one case, seizures were associated with port-wine stains in V1 alone or V1 and V2 trigeminal dermatomes location. The age of onset of seizures ranged from birth to 23 years; 75% had onset of seizures before 1 year of age; these children had an 83% incidence of developmental and academic problems. Fifty-eight percent showed early developmental delay and required special education classes. The rate of retardation showed a decreasing tendency with increasing age of onset of seizures; of the children without seizures, only 6% had developmental delay and 11% required special education classes. Glaucoma was present in 48% of patients (67% unilateral and 33% bilateral). Of all patients with glaucoma, 92% had port-wine stains in both V1 and V2 dermatomes and 8% only in V1. The laterality of glaucoma did not correspond to the trigeminal distribution of the port-wine stains in all instances. Glaucoma was diagnosed during the 1st year of life in 61% and by 5 years in 72%; one patient did not have onset of symptoms until 38 years. The results of our data can serve as a guide for estimating relative risk figures for seizures, glaucoma, and mental retardation in children with Sturge-Weber syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7769179     DOI: 10.1177/088307389501000113

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  54 in total

1.  Cell proliferation and oxidative stress pathways are modified in fibroblasts from Sturge-Weber syndrome patients.

Authors:  Shilpa D Kadam; Marjan Gucek; Robert N Cole; Paul A Watkins; Anne M Comi
Journal:  Arch Dermatol Res       Date:  2012-03-10       Impact factor: 3.017

Review 2.  Current Therapeutic Options in Sturge-Weber Syndrome.

Authors:  Anne Comi
Journal:  Semin Pediatr Neurol       Date:  2015-11-11       Impact factor: 1.636

3.  Predictors of Cognitive Functions in Children With Sturge-Weber Syndrome: A Longitudinal Study.

Authors:  Edit Bosnyák; Michael E Behen; William C Guy; Eishi Asano; Harry T Chugani; Csaba Juhász
Journal:  Pediatr Neurol       Date:  2016-05-30       Impact factor: 3.372

4.  Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome.

Authors:  Matthieu Randon; Christine Lévy-Gabriel; Rachid Abbas; Rémi Dendale; Livia Lumbroso; Laurence Desjardins; Nathalie Cassoux
Journal:  Eye (Lond)       Date:  2018-02-06       Impact factor: 3.775

5.  Cortical calcification in Sturge-Weber Syndrome on MRI-SWI: relation to brain perfusion status and seizure severity.

Authors:  Jianlin Wu; Bisher Tarabishy; Jiani Hu; Yanwei Miao; Zhaocheng Cai; Yang Xuan; Michael Behen; Meng Li; Yongquan Ye; Richard Shoskey; E Mark Haacke; Csaba Juhász
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

Review 6.  Presentation, diagnosis, pathophysiology, and treatment of the neurological features of Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

7.  EEG evolution in Sturge-Weber syndrome.

Authors:  Eric H Kossoff; Catherine D Bachur; Angela M Quain; Joshua B Ewen; Anne M Comi
Journal:  Epilepsy Res       Date:  2014-02-03       Impact factor: 3.045

8.  Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset.

Authors:  Alyssa M Day; Adrienne M Hammill; Csaba Juhász; Anna L Pinto; E Steve Roach; Charles E McCulloch; Anne M Comi
Journal:  Pediatr Neurol       Date:  2018-11-24       Impact factor: 3.372

Review 9.  [Sturge-Weber syndrome].

Authors:  W Reith; U Yilmaz; A Zimmer
Journal:  Radiologe       Date:  2013-12       Impact factor: 0.635

10.  Imaging increased glutamate in children with Sturge-Weber syndrome: Association with epilepsy severity.

Authors:  Csaba Juhász; Jiani Hu; Yang Xuan; Harry T Chugani
Journal:  Epilepsy Res       Date:  2016-02-27       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.